Long-term Top 10 — Health Care · 19 Aug 2026 →
Long-term Top 10 — Health Care — what changed on 18 Aug 2026
A dated record of one session: what entered or left, what moved inside the ten and by how much, who is closest to the boundary, and how the list did against its benchmark. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100.
The long-term score is a published weighted sum of percentile ranks, rebalanced on the first trading day of each month. A list is a published formula and its output, not a recommendation. Method version 1.
Get this list's changes by email
Who entered, who left, and the reason — with the score moves behind it.
Informational only — not financial advice. The daily email has not started yet — subscribing now puts you on the list for the first one. Unsubscribe in one click.
Membership changes on 18 Aug 2026
Entered
- Amgen (AMGN) (rank 0 → 3)
Entered 18 Aug 2026: first selection for this list at rank 3, score 62.9. - Bristol Myers Squibb (BMY) (rank 0 → 6)
Entered 18 Aug 2026: first selection for this list at rank 6, score 59.1. - Quest Diagnostics (DGX) (rank 0 → 9)
Entered 18 Aug 2026: first selection for this list at rank 9, score 56.2. - Johnson & Johnson (JNJ) (rank 0 → 5)
Entered 18 Aug 2026: first selection for this list at rank 5, score 60.4. - LIGAND PHARMACEUTICALS INC (LGND) (rank 0 → 4)
Entered 18 Aug 2026: first selection for this list at rank 4, score 61.7. - Lilly (Eli) (LLY) (rank 0 → 1)
Entered 18 Aug 2026: first selection for this list at rank 1, score 66.0. - NATIONAL HEALTHCARE CORP (NHC) (rank 0 → 7)
Entered 18 Aug 2026: first selection for this list at rank 7, score 57.8. - ResMed (RMD) (rank 0 → 2)
Entered 18 Aug 2026: first selection for this list at rank 2, score 65.3. - Royalty Pharma (RPRX) (rank 0 → 8)
Entered 18 Aug 2026: first selection for this list at rank 8, score 57.2. - West Pharmaceutical Services (WST) (rank 0 → 10)
Entered 18 Aug 2026: first selection for this list at rank 10, score 56.2.
Inside the ten
This is the first session on record for this list, so there is nothing yet to compare against.
| Company | Rank | Score | Pillar that moved most |
|---|---|---|---|
| Lilly (Eli) (LLY) | 1 | 66.0 0.0 | no pillar moved materially |
| ResMed (RMD) | 2 | 65.3 0.0 | no pillar moved materially |
| Amgen (AMGN) | 3 | 62.9 0.0 | no pillar moved materially |
| LIGAND PHARMACEUTICALS INC (LGND) | 4 | 61.7 0.0 | no pillar moved materially |
| Johnson & Johnson (JNJ) | 5 | 60.4 0.0 | no pillar moved materially |
| Bristol Myers Squibb (BMY) | 6 | 59.1 0.0 | no pillar moved materially |
| NATIONAL HEALTHCARE CORP (NHC) | 7 | 57.8 0.0 | no pillar moved materially |
| Royalty Pharma (RPRX) | 8 | 57.2 0.0 | no pillar moved materially |
| Quest Diagnostics (DGX) | 9 | 56.2 0.0 | no pillar moved materially |
| West Pharmaceutical Services (WST) | 10 | 56.2 0.0 | no pillar moved materially |
At the edge
Knocking
- Universal Health Services (UHS) 0.5 below the lowest member
- PACS GROUP INC (PACS) 0.6 below the lowest member
Closest to the exit
- Royalty Pharma (RPRX) 4.0 above the score at rank 15, where the hold band ends
- Quest Diagnostics (DGX) 3.0 above the score at rank 15, where the hold band ends
- West Pharmaceutical Services (WST) 3.0 above the score at rank 15, where the hold band ends
Ranked against 58 eligible Health Care companies on this session. A company at the edge is a company near a boundary, not a prediction that it will cross one.
Against the benchmark
Tracked since 2026-08-18 — the first session has not closed yet, so there is no return to report.
More
Informational only — NOT financial advice.